Health TrialsbyHealthPanel

HISTOLOGICAL RESULTS IN TRANSGENDER INDIVIDUALS ASSIGNED TO FEMALES AT BIRTH UNDERGOING GENDER AFFIRMATION SURGERY AND IN TESTOSTERONE THERAPY

ConditionsPregnancySmoking BehaviorTestosterone Replacement TherapyDrugsComorbidities and Coexisting ConditionsGynecological SurgeryTransgender MenGender Affirmation SurgeryHormone Replacement TherapyGynecological Disorders
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna

About this trial

The aim of this study is to report histological results of genital organs removed during gender affirmg surgery in transgender people assigned female at birth (AFAB), to increase the knowledge about the long-term effects of gender affirming hormone therapy with testosterone on these organs and to evaluate the incidence of benign and malign gynecological pathology in AFAB transgender people.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

gender incongruence diagnosis

people assigned female at birth

age >18 years

gender affirming surgery with hysterectomy

Disqualifiers

previous gynecological surgery

previous gynecological disorder diagnosis

Trial population

transgender people assigned female at birth undergoing gender affirming surgery with hysterectomy and on testosterone therapy

Trial design

Design model

Other

Time perspective

Retrospective

Treatments tested in this trial

  • analysis of medical records

    Other intervention

    analysis of medical records of the patients

Treatment groups

100 Participants
are divided into 1 treatment group
Group A: AFAB TG1 intervention

Trial outcomes

Primary outcomes

1

histological description of genital organs

Time frame
6 months

Secondary outcomes

1

prevalence of malignant and benign gynecological pathology

Time frame
6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: